Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies

Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies

by Mihajlo (Michael) Jakovljevic,Tetsuji Yamada

  • Publisher : Frontiers Media SA
  • Release : 2017-11-23
  • Pages : 129
  • ISBN : 2889453200
  • Language : En, Es, Fr & De
GET BOOK

This Research Topic was focused on provision of novel medical technologies worldwide keeping in mind financial sustainability challenge. An exemplary area certainly are oncology pharmaceuticals where prices have increased 10-fold in recent years leading to concerns on affordability. The objective of this collection of studies was to reveal some of the hidden underlying causes of unequal access to the medicines. Another core issue is the growing proportion of out-of-pocket health spending in many world regions. In line with the joint efforts of the editors and authors we received an exceptionally high response worldwide. This E-Book attracted a total of 37 self-standing research submissions out of which 32 ultimately passed external peer review and got published. Base affiliations of the authors spread across academia, pharmaceutical and medical device industry, governmental authorities and clinical medicine. Their home institutions were situated in fifteen different countries inclusive of Japan, Israel, Russia, USA, Germany, Italy, Netherlands, Austria, Spain, Malta, Serbia, Poland, Bulgaria, Hungary and Malaysia. We frankly believe that authors succeeded to cover important literature gaps referring to these world regions. We solicit global professional audience to put our efforts to the test and read this contribution to the health economics literature.

Statistical Topics in Health Economics and Outcomes Research

Statistical Topics in Health Economics and Outcomes Research
A Book

by Demissie Alemayehu, PhD,Joseph C. Cappelleri, PhD,Birol Emir, PhD,Kelly H. Zou, PhD, Pstat

  • Publisher : CRC Press
  • Release : 2017-11-22
  • Pages : 190
  • ISBN : 1351252674
  • Language : En, Es, Fr & De
GET BOOK

With ever-rising healthcare costs, evidence generation through Health Economics and Outcomes Research (HEOR) plays an increasingly important role in decision-making about the allocation of resources. Accordingly, it is now customary for health technology assessment and reimbursement agencies to request for HEOR evidence, in addition to data from clinical trials, to inform decisions about patient access to new treatment options. While there is a great deal of literature on HEOR, there is a need for a volume that presents a coherent and unified review of the major issues that arise in application, especially from a statistical perspective. Statistical Topics in Health Economics and Outcomes Research fulfils that need by presenting an overview of the key analytical issues and best practice. Special attention is paid to key assumptions and other salient features of statistical methods customarily used in the area, and appropriate and relatively comprehensive references are made to emerging trends. The content of the book is purposefully designed to be accessible to readers with basic quantitative backgrounds, while providing an in-depth coverage of relatively complex statistical issues. The book will make a very useful reference for researchers in the pharmaceutical industry, academia, and research institutions involved with HEOR studies. The targeted readers may include statisticians, data scientists, epidemiologists, outcomes researchers, health economists, and healthcare policy and decision-makers.

Challenges of Pharmacoeconomics in Global Health Arena

Challenges of Pharmacoeconomics in Global Health Arena
A Book

by Mihajlo (Michael) Jakovljevic,Nick Verhaeghe,Kyriakos Souliotis

  • Publisher : Frontiers Media SA
  • Release : 2019-03-01
  • Pages : 129
  • ISBN : 2889457591
  • Language : En, Es, Fr & De
GET BOOK

The pace of globalization has significantly accelerated since the end of the Cold War Era in 1989. These changes profoundly affected health care systems worldwide. Health policy makers increasingly started facing new harsh challenges in their uneasy task to provide universal health coverage and decent equity of access to medical services. Among the most prominent demand-side issues are extended longevity joined with population aging, rise of non-communicable diseases, and growing patient expectations. Supply-side causes are gains in societal welfare and living standards, technological innovation in medicine and continuing rapid urbanization in developing world regions. Successful insurance-based risk sharing agreements made drug dispensing and medical service provision cheap or virtually free at the point of consumption in most OECD and many middle-income countries. Coupled with massive build-up of workforce capacities and strengthening of primary care and hospital networks, all these factors contributed to the “supplier induced demand” phenomenon. There is straightforward historical evidence of long-term growth in pharmaceutical and overall health spending both in absolute and GDP% terms worldwide. The accumulated constraints deriving from skyrocketing costs of care were felt in many areas of clinical medicine even among the richest societies. Cardinal examples of expensive and hardly affordable therapeutic areas are orphan drugs indicated to treat rare diseases and targeted biologicals used in autoimmune disorders and cancer. Last but not least, is troubled and frequently denied access to even essential generic pharmaceuticals still taking place in many nations. This appears to be particularly the case among the world's poor and under-served citizens residing in rural and suburban areas of low- and middle-income countries. To a large extent, these difficulties are worsened by lack of evidence-based resource allocation strategies and less sustainable financing strategies.

Adopting New Medical Technology

Adopting New Medical Technology
A Book

by Institute of Medicine,Committee on Technological Innovation in Medicine

  • Publisher : National Academies Press
  • Release : 1994-02-01
  • Pages : 240
  • ISBN : 0309050359
  • Language : En, Es, Fr & De
GET BOOK

What information and decisionmaking processes determine how and whether an experimental medical technology becomes accepted and used? Adopting New Medical Technology reviews the strengths and weaknesses of present coverage and adoption practices, highlights opportunities for improving both the decisionmaking processes and the underlying information base, and considers approaches to instituting a much-needed increase in financial support for evaluative research. Essays explore the nature of technological change; the use of technology assessment in decisions by health care providers and federal, for-profit, and not-for-profit payers; the role of the courts in determining benefits coverage; strengthening the connections between evaluative research and coverage decisionmaking; manufacturers' responses to the increased demand for outcomes research; and the implications of health care reform for technology policy.

Rare Diseases Epidemiology: Update and Overview

Rare Diseases Epidemiology: Update and Overview
A Book

by Manuel Posada de la Paz,Domenica Taruscio,Stephen C. Groft

  • Publisher : Springer
  • Release : 2017-12-06
  • Pages : 667
  • ISBN : 3319671448
  • Language : En, Es, Fr & De
GET BOOK

The fields of rare diseases research and orphan products development continue to expand with more products in research and development status. In recent years, the role of the patient advocacy groups has evolved into a research partner with the academic research community and the bio-pharmaceutical industry. Unique approaches to research and development require epidemiological data not previously available to assist in protocol study design and patient recruitment for clinical trials required by regulatory agencies prior to approval for access by patents and practicing physicians.

New Health Technologies

New Health Technologies
Managing Access, Value and Sustainability

by Collectif

  • Publisher : OECD
  • Release : 2017-02-03
  • Pages : 129
  • ISBN : 9264266445
  • Language : En, Es, Fr & De
GET BOOK

This report discusses the need for an integrated and cyclical approach to managing health technology in order to mitigate clinical and financial risks, and ensure acceptable value for money. The analysis considers how health systems and policy makers should adapt in terms of development, assessment and uptake of health technologies. The first chapter provides an examination of adoption and impact of medical technology in the past and how health systems are preparing for continuation of such trends in the future. Subsequent chapters examine the need to balance innovation, value, and access for pharmaceuticals and medical devices, respectively, followed by a consideration of their combined promise in the area of precision medicine. The final chapter examines how health systems can make better use of health data and digital technologies. The report focuses on opportunities linked to new and emerging technologies as well as current challenges faced by policy makers, and suggests a new governance framework to address these challenges.

Cystic Fibrosis

Cystic Fibrosis
ERS Monograph

by Marcus A. Mall,J. Stuart Elborn

  • Publisher : European Respiratory Society
  • Release : 2014-06-01
  • Pages : 336
  • ISBN : 1849840512
  • Language : En, Es, Fr & De
GET BOOK

Cystic fibrosis (CF) is one of the most common fatal hereditary diseases. The discovery of the cystic fibrosis transmembrane conductance regulator (CFTR) gene 25 years ago set the stage for unraveling the pathogenesis of CF lung disease, continuous refinement of symptomatic treatments and the development of mutation-specific therapies, which are now becoming available for a subgroup of patients. This ERS Monograph provides an update on all aspects of CF lung disease, from infancy to adulthood, including current concepts on disease process, improvements in early diagnosis and monitoring, therapeutic approaches, and patient care. The book highlights important recent developments and discusses the next steps that will be required for further improvement of the life expectancy and quality of life of CF patients. It will be an essential reference for basic and clinical scientists and all members of the CF team.

Health Care Policy In East Asia: A World Scientific Reference (In 4 Volumes)

Health Care Policy In East Asia: A World Scientific Reference (In 4 Volumes)
A Book

by Anonim

  • Publisher : World Scientific
  • Release : 2019-11-25
  • Pages : 1280
  • ISBN : 9813236124
  • Language : En, Es, Fr & De
GET BOOK

During the past three decades, health care systems in the East Asian regions of China, Japan, South Korea, and Taiwan have undergone major changes. Each system has its unique achievements and challenges. Global health care policymakers are increasingly interested in understanding the changes that have taken place in these four systems. This four-volume reference set is designed to help health care professionals, academics, policymakers, and general readers gain a good grasp of the background and latest developments in the health care systems of China, Japan, South Korea, and Taiwan. This reference set provides an in-depth comparative health policy analysis and discussion of health care reform strategies in each of these systems. One unique feature of this set is that each volume has been edited by a leading scholar who has been deeply involved in the development of the health care system in that particular region. Each of these editors also has invited both scholars and practitioners to provide a first-hand description and analysis of key health care reform issues in that system. The many examples provided in each volume demonstrate how findings of evidence-based policy research can be implemented into policy practice.Volume 1 describes and discusses China's ambitious and complex journey of health care reform since 2009. The Chinese government has achieved universal health insurance coverage and has embarked on reforms of the service delivery system and provider payment methods that are aimed at controlling health expenditure growth and improving efficiency. This volume includes pilot and social experiments initiated by the government and researchers and their evaluations that have guided the formulation of health reform policies. It provides information on how to make reforms work at the local and provincial levels. The findings detailed in this volume will contribute to a global knowledge base in health care reforms.Volume 2 provides a comprehensive review and evaluation of the Japanese health care system. Japan has a long history of health care system development and provision of universal health coverage, with a mature and well-developed health care system among East Asian countries. However, due to increases in health care costs, economic stagnation and the country's rapidly aging population, Japan has undergone significant health care reform during the last two decades, both in the delivery as well as financing of health services in its hospital sector, medical technology sector and long-term care insurance. Despite these challenges and reforms, health outcomes among the Japanese population have been progressively among the best in the world. This volume shows how policy research can lead to policy analysis, implementation and assessment. It also provides valuable lessons learnt for mutual learning among other health care systems.Volume 3 offers a comprehensive review of the developments in South Korea's national health insurance system since 1989 in terms of financing, delivery systems, and outcomes. The volume analyzes the efficiency of cost and service delivery by public sectors versus private sectors. It points out areas of challenge to future Korean health care reform. Chapter authors in this volume are leading experts involved in Korean health care policy implementation.Volume 4 reviews the development and achievements of Taiwan Health Insurance since 1995. Because of its continuous reform in payment, services delivery, and pharmaceutical technology, Taiwan has been considered a model example of universal health insurance among global health systems. This volume shows the processes used to translate policy research findings into policy changes. While the health care reform in Taiwan is ongoing, the Taiwan example provides a real-world and practical understanding of health care system changes.In summary, this four-volume set makes an outstanding contribution to health care system reform and policy research, based on solid scholarly work. It also introduces policy researchers and academic communities to current debates about health systems, health financing, and universal health coverage. This reference volume is a must for anyone keen on East Asia's health care system reform dynamics and changing scene.

The Future of Health Economics

The Future of Health Economics
A Book

by Olivier Ethgen,Ulf Staginnus

  • Publisher : Taylor & Francis
  • Release : 2016-10-14
  • Pages : 284
  • ISBN : 1317031121
  • Language : En, Es, Fr & De
GET BOOK

The pharmaceutical industry faces a well-documented perfect storm: on the one hand, the patent cliff; the lack of new blockbusters and, on the other, economic pressure on pricing from markets with growing expectations and shrinking budgets. In the face of such pressure, traditional health economics models no longer seem appropriate and yet what do we have to replace them? The growing focus on 'value' and 'cost effectiveness' are evidence of new emerging thinking although, even here, with the shift from medicine as cure to medicine as palliative, as a treatment for chronic illness and with the growing emphasis on preventative approaches, the landscape is complex and challenging. The Future of Health Economics offers a window into some of the most influential emerging issues in pharmacoeconomics; issues such as risk-sharing and alternative pricing models or the potential impact of radical new approaches such as personalized medicine; as well as exploring the changing role of government and regulators. Ulf Staginnus and Olivier Ethgen, themselves two of the most well-regarded practitioners in this field, have brought together some leading-edge thinkers from industry and academia around the world to provide the industry, policy-makers, regulators, health practitioners and academics with the raw material for their future scenarios.

United States-China Economic Relations and China's Role in the World Economy

United States-China Economic Relations and China's Role in the World Economy
Hearing Before the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, First Session, April 14, 2005

by United States. Congress. House. Committee on Ways and Means

  • Publisher : Unknown Publisher
  • Release : 2005
  • Pages : 201
  • ISBN : 9876543210XXX
  • Language : En, Es, Fr & De
GET BOOK

The Role of Market Forces in the Delivery of Health Care

The Role of Market Forces in the Delivery of Health Care
Issues for Research

by Anonim

  • Publisher : Unknown Publisher
  • Release : 1984
  • Pages : 11
  • ISBN : 9876543210XXX
  • Language : En, Es, Fr & De
GET BOOK

Encyclopedia of Pharmacy Practice and Clinical Pharmacy

Encyclopedia of Pharmacy Practice and Clinical Pharmacy
A Book

by Anonim

  • Publisher : Academic Press
  • Release : 2019-06-28
  • Pages : 2358
  • ISBN : 0128127368
  • Language : En, Es, Fr & De
GET BOOK

Encyclopedia of Pharmacy Practice and Clinical Pharmacy covers definitions, concepts, methods, theories and applications of clinical pharmacy and pharmacy practice. It highlights why and how this field has a significant impact on healthcare. The work brings baseline knowledge, along with the latest, most cutting-edge research. In addition, new treatments, algorithms, standard treatment guidelines, and pharmacotherapies regarding diseases and disorders are also covered. The book's main focus lies on the pharmacy practice side, covering pharmacy practice research, pharmacovigilance, pharmacoeconomics, social and administrative pharmacy, public health pharmacy, pharmaceutical systems research, the future of pharmacy, and new interventional models of pharmaceutical care. By providing concise expositions on a broad range of topics, this book is an excellent resource for those seeking information beyond their specific areas of expertise. This outstanding reference is essential for anyone involved in the study of pharmacy practice. Provides a ‘one-stop’ resource for access to information written by world-leading scholars in the field Meticulously organized, with articles split into three clear sections, it is the ideal resource for students, researchers and professionals to find relevant information Contains concise and accessible chapters that are ideal as an authoritative introduction for non-specialists and readers from the undergraduate level upwards Includes multimedia options, such as hyperlinked references and further readings, cross-references and videos

The Implications of Cost-effectiveness Analysis of Medical Technology

The Implications of Cost-effectiveness Analysis of Medical Technology
A Book

by Anonim

  • Publisher : Unknown Publisher
  • Release : 1980
  • Pages : 129
  • ISBN : 9876543210XXX
  • Language : En, Es, Fr & De
GET BOOK

New Medical Devices

New Medical Devices
Invention, Development, and Use

by Institute of Medicine,National Academy of Engineering

  • Publisher : National Academies Press
  • Release : 1988-01-01
  • Pages : 204
  • ISBN : 0309038472
  • Language : En, Es, Fr & De
GET BOOK

In the past 50 years the development of a wide range of medical devices has improved the quality of people's lives and revolutionized the prevention and treatment of disease, but it also has contributed to the high cost of health care. Issues that shape the invention of new medical devices and affect their introduction and use are explored in this volume. The authors examine the role of federal support, the decision-making process behind private funding, the need for reforms in regulation and product liability, the effects of the medical payment system, and other critical topics relevant to the development of new devices.

Including a Symposium on Mary Morgan

Including a Symposium on Mary Morgan
Curiosity, Imagination, and Surprise

by Luca Fiorito,Scott Scheall,Carlos Eduardo Suprinyak

  • Publisher : Emerald Group Publishing
  • Release : 2018-10-24
  • Pages : 256
  • ISBN : 1787564231
  • Language : En, Es, Fr & De
GET BOOK

Volume 36B of Research in the History of Economic Thought and Methodology features a symposium reflecting on the significance of Mary Morgan's contributions to the history and philosophy of economics.

Ensuring Value for Money in Health Care

Ensuring Value for Money in Health Care
The Role of Health Technology Assessment in the European Union

by Corinna Sorenson,Michael Drummond,Panos Kanavos

  • Publisher : WHO Regional Office Europe
  • Release : 2008
  • Pages : 156
  • ISBN : 9289071834
  • Language : En, Es, Fr & De
GET BOOK

This report addresses the concepts and controversy surrounding health technology assessment in Europe, with a particular focus on selected Member States including Sweden, the Netherlands, Finland, France, Germany and the United Kingdom. It is intended to identify and address current considerations regarding HTA methodological and process issues related to the prioritization and financing of modern health care. In particular, it describes the processes and challenges for identifying and prioritizing assessments; assesses and compares current assessment methods and procedures; and highlights the barriers to effective implementation. The report also ascertains the roles and terms of engagement of key stakeholders, and captures the opportunities and challenges for the use of HTA guidance in general priority-setting, decision-making and health-care provision.

Critical Challenges for Health Care Reform in Europe

Critical Challenges for Health Care Reform in Europe
A Book

by Richard B. Saltman,Josep Figueras,Constantino Sakellarides

  • Publisher : McGraw-Hill Education (UK)
  • Release : 1998-10-16
  • Pages : 424
  • ISBN : 033523268X
  • Language : En, Es, Fr & De
GET BOOK

This volume explores the central issues driving the present process of healthcare reform in Europe. 17 chapters written by scholars and policy makers from all parts of Europe draw together the available evidence from epidemiology and public health, economics, public policy, organizational behaviour and management theory as well as real world policy making experience, laying out the options that health sector decision-makers confront. Through its cross-disciplinary, cross-national approach, the book highlights the underlying trends that now influence health policy formulation across Europe. An authoritative introduction provides a broad synthesis of present trends and strategies in European health policy.

Journal of the National Cancer Institute

Journal of the National Cancer Institute
Monographs

by Anonim

  • Publisher : Unknown Publisher
  • Release : 1990
  • Pages : 129
  • ISBN : 9876543210XXX
  • Language : En, Es, Fr & De
GET BOOK

Principles and Practice of Pharmaceutical Medicine

Principles and Practice of Pharmaceutical Medicine
A Book

by Andrew J. Fletcher,Lionel D. Edwards,Anthony W. Fox,Peter D. Stonier

  • Publisher : John Wiley & Sons
  • Release : 2003-01-31
  • Pages : 556
  • ISBN : 0470851716
  • Language : En, Es, Fr & De
GET BOOK

Principles and Practice of Pharmaceutical Medicine begins with a detailed overview of its origins, and goes on to examine current career opportunities, education and training. Encompassing the entire spectrum of pharmaceutical medicine, it also discusses international drug development and registration, including animal toxicology and human volunteers, pharmacoeconomics and statistics, medical services, legal and ethical issues and business aspects. It is the most up-to-date guide to drug development and marketing, and the only book with an international outlook. * The authors are all experts in their field and include an assessment of the current status of their specialities * This book provides an insight into how things may develop in the future * It is designed to be a guide for those who are actually practicing pharmaceutical medicine

Health Technology Assessment in Japan

Health Technology Assessment in Japan
Policy, Pharmacoeconomic Methods and Guidelines, Value, and Beyond

by Isao Kamae

  • Publisher : Springer Nature
  • Release : 2019-09-03
  • Pages : 265
  • ISBN : 9811357935
  • Language : En, Es, Fr & De
GET BOOK

Representing the first book on the topic, this work offers the reader an introduction to the Japanese systems for health technology assessment (HTA) officially introduced by the Ministry of Health, Labour and Welfare (MHLW) in 2016. Policy and guidelines are discussed, with the relevant methods and conditions of cost-effectiveness analysis explained alongside. Numerous instructive examples and exercises, ranging from basic to advanced, impart valuable knowledge and insight on the quantitative methods for economic evaluation, which will appeal to both beginners and experts. This guidebook is authored by Japan’s foremost expert in HTA and pharmacoeconomics, with a view to strengthening the reader’s expertise in value-based healthcare and decision-making. The methods presented are essential to informing regulatory, local and patient decisions; as such, the book is equally recommended to industry and government, as well as academia, and anyone with an interest in Japanese HTA.